Related Articles
Somatostatin analogues inhibit cancer cell proliferation in an SSTR2-dependent manner via both cytostatic and cytotoxic pathways
Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B‑related hepatocellular carcinoma following octreotide long‑acting release treatment
Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells
Inhibitory effects of somatostatin on tumor necrosis factor-α-induced interleukin-6 secretion in human pancreatic periacinar myofibroblasts
Expression, purification, refolding, and characterization of octreotide-interleukin-2: A chimeric tumor-targeting protein